Celldeg

Celldeg

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CellDEG is a private, pre-revenue platform company commercializing a novel photobioreactor technology that enables ultra-high-density cultivation of microalgae and cyanobacteria. Its proprietary system uses a vibrating membrane for bubble-free gas exchange and turbulent mixing, addressing key limitations of traditional reactors like carbon limitation and oxygen stress. This allows for biomass concentrations up to 30g/L and productivities up to 10g/L/day, positioning the technology as a potential game-changer for scaling photosynthetic production of biofuels, chemicals, and other bioproducts. The company currently sells lab-scale systems to academic and industrial research customers.

Cell TherapyRegenerative Medicine

Technology Platform

Patented High-Density Cultivation (HDC) technology using membrane photobioreactors. Features bubble-free, membrane-mediated CO2/O2 exchange, turbulent mixing via a vibrating membrane, and enables ultra-high cell density growth of photoautotrophs under extreme light intensity without photoinhibition.

Opportunities

The technology addresses a major bottleneck in scaling photosynthetic production for the multi-billion dollar markets in sustainable biofuels, chemicals, nutraceuticals, and biotherapeutics.
Successful scale-up of the reactor systems from lab to industrial production could position CellDEG as a key enabler of the algae-based bioeconomy.

Risk Factors

Key risks include the technical and economic challenges of scaling the membrane bioreactor technology to industrial production volumes.
The company also faces competition from established bioreactor manufacturers and must convince a traditionally conservative market to adopt a novel platform technology.

Competitive Landscape

CellDEG competes with traditional photobioreactor manufacturers (e.g., Sartorius, Photon Systems Instruments) and bubble column suppliers. Its primary competitive advantage is its unique membrane technology that enables significantly higher cell densities and productivities, a claim supported by academic testimonials. It occupies a specialized niche within the broader bioreactor market.